medtronic

  1. T

    Medtronic Announces Global Launch Of New Heart Valve Repair Ring

    Medtronic, Inc. (NYSE: MDT) announced the global launch and first clinical use of the Tri-Ad™ Semi-Flexible Tricuspid Annuloplasty Ring for the treatment of tricuspid valve disease. The ring is designed to adapt to the movement of a diseased patient's natural valve to help restore the valve to...
  2. T

    Medtronic Marks Bladder Health Awareness Month With National Women's Health Campaign

    In support of Bladder Health Awareness Month and the struggles 33 million Americans face year-round with bladder control issues, Medtronic, Inc. (NYSE: MDT) is extending its national women's health campaign, Facing Our Moments Together™. The campaign, conducted in partnership with leading...
  3. T

    Medtronic Settles US Lawsuits On Sprint Fidelis Family Of Defibrillation Leads

    Medtronic, Inc. (NYSE:MDT) announced that it has entered into an agreement to settle existing U.S. lawsuits relating to its Sprint Fidelis® family of defibrillation leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949) that were the subject of a field action announced on October 15, 2007. Under...
  4. T

    Medtronic Hydrodebrider™ System Wins Medical Device Excellence Award

    Medtronic (NYSE: MDT) announced that the company was named a 2010 Medical Device Excellence Award (MDEA) winner for excellence in medical device design for its Hydrodebrider™ System , manufactured by the company's Ear Nose and Throat (ENT) business unit. The Hydrodebrider System is the first...
  5. T

    Medtronic Launches New Frontal Handpiece For Its Hydrodebrider™ System

    Medtronic (NYSE: MDT) announced today the launch of a new Frontal Handpiece for its Hydrodebrider™ System, manufactured by the company's Ear Nose and Throat (ENT) division. The Hydrodebrider System is the first and only powered endoscopic irrigation system for removing bacteria from the...
  6. T

    Medtronic Starts International Study Of CoreValve(R) Transcatheter Aortic Valve Syste

    Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc. (NYSE: MDT), announced the start of the first of several new initiatives in a robust international clinical program for its CoreValve transcatheter aortic valve system, a minimally-invasive...
  7. T

    Medtronic's Strong Earnings Reassure Defibrillator Industry

    Medical technology company Medtronic's stocks surged 5 percent Tuesday in the wake of strong earnings reports, while rivals on implantable cardioverter defibrillators (ICD) market saw similar gains in the neighborhood of 4 percent, Dow Jones/Wall Street Journal reports. ICDs monitor patient's...
Back
Top